Name | tunicamycin A |
---|---|
Synonyms |
(+)-tunicamycin V
tunicamycin B tunicamycin V tunicamycin-V tunicamycin |
Description | Tunicamycin V (Tunicamycin A) is a nucleoside natural product that inhibits bacterial phospho-N-acetylmuramyl-pentapeptide transferase (MraY) with an IC50 of 0.35 μM. Tunicamycin V has antibacterial activties[1][2]. |
---|---|
Related Catalog | |
Target |
IC50: 0.35 μM (phospho-N-acetylmuramyl-pentapeptide transferase (MraY))[1] |
In Vitro | Tunicamycins are nucleoside natural products isolated from the fermentation broths of Streptomyces lysosuperficus in 1971 and exhibit a variety of biological properties including antibacterial, antiviral, antifungal, and antitumor activities. Tunicamycins strongly inhibit UDP-N-acetylglucosamine (GlcNAc): polyprenol phosphate translocase, the enzyme responsible for the first N-acetylglucosamination of the N-linked glycopeptide in endothelial reticulum (ER)[2]. |
References |
[2]. Kazuki Yamamoto, et al. Total Synthesis of Tunicamycin V. Org Lett. 2018 Jan 5;20(1):256-259. |
Molecular Formula | C38H62N4O16 |
---|---|
Molecular Weight | 830.91600 |
Exact Mass | 830.41600 |
PSA | 311.82000 |